Medicare Enrolled

Dr. Hernan Giraldo, MD

Pulmonary Disease · Tampa, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
6101 WEBB RD STE 208, Tampa, FL 33615
8138897653
Registered in NPPES since 2005
NPI: 1740278506 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Giraldo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Giraldo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Giraldo

Dr. Hernan Giraldo is a pulmonary disease specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Giraldo performed 710 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Giraldo received a total of $7,805 from 29 pharmaceutical and/or device companies across 323 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Giraldo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 710 Medicare services $7,805 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 37010 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
710
Medicare services
Bottom 35% in FL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $89 $157
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
147 $130 $211
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
37 $13 $25
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
36 $28 $89
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
36 $40 $65
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
36 $33 $50
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
36 $43 $65
New patient office visit, complex (60-74 min) 28 $145 $303
Positive pressure ventilator therapy
A therapy procedure that uses a positive pressure ventilator to assist with breathing.
22 $49 $100
Home sleep study test with type II portable monitor
An unattended sleep study performed at home using a portable monitor that records at least seven channels, including brain activity, eye movement, muscle activity, heart rate, airflow, breathing effort, and oxygen levels.
21 $107 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,805
Total received (2018-2024)
Avg $1,115/year across 7 years
Top 27% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
323
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,592
2023
$1,489
2022
$867
2021
$1,042
2020
$901
2019
$1,095
2018
$819

Payments by company (2024)

GlaxoSmithKline, LLC.
$442
AstraZeneca Pharmaceuticals LP
$351
JAZZ PHARMACEUTICALS INC.
$314
GENZYME CORPORATION
$188
Amgen Inc.
$102
Regeneron Healthcare Solutions, Inc.
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Actelion Pharmaceuticals US, Inc.
$26
Paratek Pharmaceuticals, Inc.
$24
3B Medical, Inc.
$18
Top 3 companies account for 69.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,810
GlaxoSmithKline, LLC.
$1,804
JAZZ PHARMACEUTICALS INC.
$1,085
Jazz Pharmaceuticals Inc.
$618
Boehringer Ingelheim Pharmaceuticals, Inc.
$372
GENZYME CORPORATION
$356
Bayer Healthcare Pharmaceuticals Inc.
$225
Novartis Pharmaceuticals Corporation
$212
Regeneron Healthcare Solutions, Inc.
$205
Actelion Pharmaceuticals US, Inc.
$198
Mylan Specialty L.P.
$182
Amgen Inc.
$130
Abbott Laboratories
$93
Cook Incorporated
$77
Insmed, Inc.
$50
Grifols USA, LLC
$50
Bayer HealthCare Pharmaceuticals Inc.
$44
Mallinckrodt Hospital Products Inc.
$39
Circassia Pharmaceuticals Inc
$34
CSL Behring
$34
Axsome Therapeutics, Inc.
$34
PFIZER INC.
$30
Paratek Pharmaceuticals, Inc.
$24
Merck Sharp & Dohme LLC
$21
Shionogi Inc
$20
3B Medical, Inc.
$18
Merck Sharp & Dohme Corporation
$14
IDORSIA PHARMACEUTICALS US INC
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · Adempas · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · COOK MEDICAL ZILVER PTX · DUPIXENT · FARXIGA · FASENRA · Fetroja · LUNA · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PAXLOVID · Proclaim Family of SCS IPGs · Prolastin-C Liquid · QUVIVIQ · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · UPTRAVI · XOLAIR · XYREM · XYWAV · Xyrem · YUPELRI · Yupelri · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Tampa?
Compare pulmonary diseases in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
101
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ST JOSEPHS HOSPITAL
4.6 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Giraldo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Giraldo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Giraldo performed 311 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Giraldo receive payments from pharmaceutical companies?
Yes. Dr. Giraldo received a total of $7,805 from 29 companies across 323 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Giraldo's costs compare to other pulmonary diseases in Tampa?
Dr. Giraldo's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Giraldo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →